Cerus Corporation Share Price

Cerus Corporation Share Price

NASDAQ: CERS | Small Cap
$2.43
+$0.02 (0.62%) Last updated on 29 Oct, 2026 | 20:35 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cerus Corporation Stock Performance

Open
$2.44
Prev. Close
$2.42
Circuit Range
N/A
Day Range
$2.41 - $2.46
Year Range
$1.38 - $3.46
Volume
13,246
Average Traded
$2.43

Cerus Corporation Share Price Today

As of 29 October 2026, Cerus Corporation's share price is $2.43. The stock opened at $2.44, compared to its previous close of $2.42. During today's trading session, Cerus Corporation's share price traded between $2.41 and $2.46, with an average price of $2.43. Over the past 52 weeks, the stock has recorded a high of $3.46 and a low of $1.38. In terms of performance, Cerus Corporation's share price has risen by 20.30% over the last six months and is up 64.19% on a year-on-year basis.

Cerus Corporation Share Price Chart

Line chart of the Cerus Corporation price trend over the selected period. The price rose overall, ranging from 2.41 to 2.46, ending at 2.43.
$2.41$2.46
L
Show Current Price
H

Cerus Corporation Stock Fundamentals & Key Indicators

Market Cap
$463.14M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.03
Revenue (TTM)
$233.80B
Return On Equity (TTM)
-9.69%
Profit Margin
-6.69%
Debt to Equity
0.93
Quarterly Earnings Growth YoY
-14600.00%

Cerus Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$60.24$64.58$59.89$63.30
Net Profit-$0.02-$2.18-$1.64-$2.94
Net Profit Margin-0.03%-3.38%-2.74%-4.64%
Income ChangeN/A-10800.00%24.77%-79.27%

Cerus Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$188.32$186.80$201.32$233.80
Net Profit-$42.78-$37.49-$20.92-$15.63
Net Profit Margin-22.72%-20.07%-10.39%-6.69%
Income ChangeN/A12.37%44.20%25.29%

About Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Cerus Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.34
$2.44
+2.53%
Sep 2026
$2.61
$2.38
-13.00%
Aug 2026
$2.20
$2.73
+26.98%
Jul 2026
$2.88
$2.15
-26.50%
Jun 2026
$3.00
$2.92
-4.10%
May 2026
$2.72
$3.05
+50.99%
Apr 2026
$1.87
$2.02
+10.99%
Mar 2026
$2.53
$1.82
-29.18%
Feb 2026
$2.34
$2.57
+9.83%
Jan 2026
$2.07
$2.34
+14.15%
Dec 2025
$1.72
$2.05
+16.48%
Nov 2025
$1.52
$1.76
+18.92%

CERS Share Price FAQs